El cierre del gobierno federal continúa, trabado por el desacuerdo en el Congreso sobre el costo del seguro médico de 22 millones de personas que tienen planes adquiridos en los mercados establecidos por la Ley de Cuidado de Salud a Bajo Precio (ACA). Mientras tanto, un nuevo informe muestra que más de 154 millones de personas con…
Equity has to be built into the deployment strategy from day one, not treated as a future retrofit. That means prioritizing inclusion not only in the data but in the delivery, and recognizing that inclusive deployment is the foundation for inclusive datasets. The post Bias Doesn’t End at the Dataset: It Lives in the Deployment…
The Health Resources and Services Administration is making a $52 million investment in 54 health centers to support the health needs of those leaving incarceration. The post HRSA Commits $52M to Health Centers Supporting People Leaving Incarceration appeared first on MedCity News.
This analysis compares 2021 data about deaths in the U.S. and 11 other large, wealthy countries by age and cause to understand the primary drivers of the longevity gap between the U.S. and the comparable countries. It finds that the primary reasons for the gap in 2021 were chronic disease, COVID-19 and substance use disorders.
That is the title of a KFF article published last week. The results are based on KFF’s 2024 Employer Health Benefits Survey. They write: For KFF’s survey of 2,142 randomly selected companies, officials from those with 500 or more employees were asked how much of the rebates negotiated by [pharmacy benefit managers] PBMs returned to…
Trust in the U.S. healthcare system is eroding, but experts say rebuilding it is possible. They say this will require both payers and providers to prioritize empathy, transparency and personalized communication. The post Americans’ Trust in the Healthcare System Is Plummeting. How Can It Be Repaired? appeared first on MedCity News.
Tim Elliott says the CMMI model will help health systems shine a light on unwarranted variations in care
As reported by EndPoints: President Donald Trump on Tuesday signed an executive order offering support for a change to the IRA’s “pill penalty,” one of the industry’s long-standing policy priorities that could affect billions of dollars in drug costs under Medicare. The executive order on drug pricing contains a grab-bag of policy proposals, some of…
The Phase 2 failure in major depressive disorder marks the second time in a little more than a year that Neurocrine Biosciences has reported a drug licensed from Takeda Pharmaceutical fell short in the clinic. Last year, a different drug from this partnership failed a mid-stage test in schizophrenia. The post Neurocrine Bio Drug Licensed…
The FDA has proposed removing oral phenylephrine from its guidelines for over-the-counter drugs due to inefficacy as a decongestant. Use of this ingredient in cold and allergy medicines grew after a federal law required that pseudoephedrine-containing products be kept behind pharmacy counters. The post FDA Takes Step Toward Removal of Ineffective Decongestants From the Market…